Chemoinformaics analysis of 2-PHENYLFURO[2,3-H]CHROMEN-4-ONE
| Molecular Weight | 262.264 | nRot | 1 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 22 |
| Exact Molecular Weight | 262.063 | nRing | 4 |
| Solubility: LogS | -6.172 | nHRing | 2 |
| Solubility: LogP | 4.368 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 19 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 21 |
| nHA | 3 | APOL | 37.4639 |
| nHD | 0 | BPOL | 14.3721 |
| QED | 0.516 |
| Synth | 2.195 |
| Natural Product Likeliness | 0.742 |
| NR-PPAR-gamma | 0.414 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.904 |
| Pgp-sub | 0.591 |
| HIA | 0.006 |
| CACO-2 | -4.709 |
| MDCK | 0.0000203 |
| BBB | 0.01 |
| PPB | 0.958376 |
| VDSS | 1.163 |
| FU | 0.0445262 |
| CYP1A2-inh | 0.987 |
| CYP1A2-sub | 0.27 |
| CYP2c19-inh | 0.759 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.573 |
| CYP2c9-sub | 0.882 |
| CYP2d6-inh | 0.438 |
| CYP2d6-sub | 0.868 |
| CYP3a4-inh | 0.333 |
| CYP3a4-sub | 0.16 |
| CL | 4.584 |
| T12 | 0.17 |
| hERG | 0.022 |
| Ames | 0.327 |
| ROA | 0.837 |
| SkinSen | 0.104 |
| Carcinogencity | 0.836 |
| EI | 0.849 |
| Respiratory | 0.807 |
| NR-Aromatase | 0.912 |
| Antiviral | Yes |
| Prediction | 0.53481 |